ArticleCancers2025

Impact of Venetoclax Treatment Schedule on Hematologic Recovery and Treatment Response in AML Patients Unfit for Intensive Chemotherapy.

Anja Schüpbach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.